Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3993 | 1792 | 35.7 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1199 | 8822 | MERKEL CELL CARCINOMA//JC VIRUS//BK VIRUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | Author keyword | 508 | 75% | 20% | 362 |
2 | JC VIRUS | Author keyword | 447 | 75% | 18% | 326 |
3 | PROGRESSIVE MULTIFOCAL | Author keyword | 76 | 93% | 2% | 28 |
4 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PML | Author keyword | 64 | 88% | 2% | 30 |
5 | NATALIZUMAB | Author keyword | 60 | 32% | 9% | 155 |
6 | JCV | Author keyword | 56 | 55% | 4% | 70 |
7 | NEUROTOXICOL SECT | Address | 37 | 81% | 1% | 22 |
8 | MOL MED NEUROSCI | Address | 27 | 41% | 3% | 52 |
9 | JC POLYOMAVIRUS | Author keyword | 25 | 73% | 1% | 19 |
10 | PML | Author keyword | 24 | 19% | 6% | 113 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | 508 | 75% | 20% | 362 | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY |
2 | JC VIRUS | 447 | 75% | 18% | 326 | Search JC+VIRUS | Search JC+VIRUS |
3 | PROGRESSIVE MULTIFOCAL | 76 | 93% | 2% | 28 | Search PROGRESSIVE+MULTIFOCAL | Search PROGRESSIVE+MULTIFOCAL |
4 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PML | 64 | 88% | 2% | 30 | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY+PML | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY+PML |
5 | NATALIZUMAB | 60 | 32% | 9% | 155 | Search NATALIZUMAB | Search NATALIZUMAB |
6 | JCV | 56 | 55% | 4% | 70 | Search JCV | Search JCV |
7 | JC POLYOMAVIRUS | 25 | 73% | 1% | 19 | Search JC+POLYOMAVIRUS | Search JC+POLYOMAVIRUS |
8 | PML | 24 | 19% | 6% | 113 | Search PML | Search PML |
9 | AGNOPROTEIN | 19 | 70% | 1% | 16 | Search AGNOPROTEIN | Search AGNOPROTEIN |
10 | JC VIRUS JCV | 18 | 89% | 0% | 8 | Search JC+VIRUS+JCV | Search JC+VIRUS+JCV |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | 231 | 30% | 36% | 645 |
2 | HUMAN POLYOMAVIRUS JC | 186 | 83% | 6% | 104 |
3 | HUMAN NEUROTROPIC POLYOMAVIRUS | 102 | 88% | 3% | 49 |
4 | JC VIRUS DNA | 91 | 62% | 5% | 94 |
5 | HUMAN PAPOVAVIRUS JC | 72 | 100% | 1% | 23 |
6 | HUMAN POLYOMAVIRUS | 70 | 55% | 5% | 87 |
7 | HUMAN NEUROTROPIC VIRUS | 50 | 84% | 2% | 27 |
8 | JC VIRUS | 50 | 24% | 10% | 179 |
9 | BK VIRUS | 44 | 27% | 8% | 142 |
10 | FETAL GLIAL CELLS | 33 | 74% | 1% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases | 2010 | 278 | 23 | 83% |
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section | 2013 | 50 | 52 | 81% |
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis | 2010 | 185 | 101 | 89% |
Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies | 2010 | 171 | 41 | 88% |
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab | 2012 | 83 | 29 | 66% |
Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease | 2007 | 88 | 78 | 85% |
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter | 2013 | 20 | 143 | 87% |
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring | 2011 | 95 | 58 | 66% |
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring | 2007 | 103 | 63 | 70% |
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project | 2009 | 188 | 51 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROTOXICOL SECT | 37 | 81% | 1.2% | 22 |
2 | MOL MED NEUROSCI | 27 | 41% | 2.9% | 52 |
3 | NEUROVIROL CANC BIOL | 18 | 31% | 2.7% | 48 |
4 | NEUROVIROL | 10 | 14% | 3.7% | 66 |
5 | MOL NEUROVIROL | 9 | 52% | 0.7% | 12 |
6 | VIRAL INFECTMINATO KU | 8 | 75% | 0.3% | 6 |
7 | NEUROVIROL NEUROL | 6 | 100% | 0.2% | 4 |
8 | CENT CYTOPATHOL | 4 | 75% | 0.2% | 3 |
9 | VIROL VACCINE MED | 4 | 75% | 0.2% | 3 |
10 | MULTIPLE SCLEROSIS CLIN DEV GRP | 3 | 100% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000230665 | BK VIRUS//HEMORRHAGIC CYSTITIS//POLYOMAVIRUS BK |
2 | 0.0000207994 | SV40//SIMIAN VIRUS 40//AERODIGEST PROGRAM |
3 | 0.0000108107 | POLYOMAVIRUS VP1//SV40 VECTORS//SECT VIROL ONCOL |
4 | 0.0000088502 | IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME//IMMUNE RESTORATION DISEASE//IMMUNE RECONSTITUTION SYNDROME |
5 | 0.0000079846 | PUR ALPHA//TEF 1//RTEF 1 |
6 | 0.0000064463 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |
7 | 0.0000063764 | BIOCHEM A703//MIDDLE T ANTIGEN//MIDDLE T |
8 | 0.0000063520 | GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B |
9 | 0.0000059147 | FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM |
10 | 0.0000043896 | MERKEL CELL CARCINOMA//MERKEL CELL POLYOMAVIRUS//MCPYV |